Pages that link to "Q35859844"

The following pages link to Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso (Q35859844):

Displaying 19 items.

• New developments in anti-malarial target candidate and product profiles (Q28468598) (← links)
• Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine (Q30234589) (← links)
• Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children (Q33612551) (← links)
• Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study (Q36018444) (← links)
• Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali (Q36143003) (← links)
• Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis (Q37607325) (← links)
• Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis (Q38642887) (← links)
• malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication (Q47134819) (← links)
• Seasonal malaria chemoprevention: successes and missed opportunities (Q47149458) (← links)
• Impact Evaluation of Seasonal Malaria Chemoprevention under Routine Program Implementation: A Quasi-Experimental Study in Burkina Faso (Q47572108) (← links)
• Comparison of home fortification with two iron formulations among Kenyan children: Rationale and design of a placebo-controlled non-inferiority trial. (Q52716577) (← links)
• Evaluation of Two Strategies for Community-Based Safety Monitoring during Seasonal Malaria Chemoprevention Campaigns in Senegal, Compared with the National Spontaneous Reporting System. (Q55410478) (← links)
• Malaria (Q56378965) (← links)
• Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children (Q61443025) (← links)
• The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data (Q89881047) (← links)
• Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial (Q91898654) (← links)
• Two-Year Scale-Up of Seasonal Malaria Chemoprevention Reduced Malaria Morbidity among Children in the Health District of Koutiala, Mali (Q99549252) (← links)
• Treatment and prevention of malaria in children (Q99569237) (← links)
• Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren (Q99591273) (← links)